item management s discussion and analysis of financial condition and results of operations this management discussion and analysis of financial condition and results of operations contains forward looking statements 
such statements involve various risks that may cause actual results to differ materially 
these risks include  but are not limited to  the ability of the company to grow internally or by acquisition and to integrate acquired businesses  changing industry or competitive conditions  and other risks referred to in the company s registration statements and periodic reports filed with the securities and exchange commission 
overview the company s net sales have increased as a result of both internal growth and acquisitions 
the company has completed three acquisitions in the past five years dynarad a designer and manufacturer of medical imaging systems and critical electronic subsystems in fiscal  bertan a designer and manufacturer of precision high voltage power supplies and instrumentation for medical and industrial applications in fiscal  and gendex del a manufacturer of medical imaging systems in fiscal the company s net sales have increased from approximately million in fiscal to approximately million in fiscal  a compounded annual growth rate of 
during the past five years the company has grown internally and through acquisitions into a company whose predominant business is serving the medical imaging and diagnostic markets 
the company s net sales attributable to medical imaging products have increased from approximately million or of total net sales in fiscal to approximately million or of total net sales and approximately million or of total net sales in fiscal years and  respectively 
management believes that recent cost containment trends in the healthcare industry have created opportunities for its cost effective medical imaging products in domestic and international markets 
some of these trends are increased demand for lower cost medical equipment  outsourcing of systems and critical electronic subsystems by leading oems  increased demand for certain diagnostic procedures and lower cost medical services in the global marketplace 
general the following discussion and analysis examines the major factors contributing to the company s financial condition and results of operations for the three years ended august   august  and july  the following discussion and analysis should be read in conjunction with the company s consolidated financial statements and notes thereto appearing elsewhere in this document 
for segment reporting purposes  the company has organized its operations based upon its manufacturing capabilities into two segments critical electronic subsystems and medical systems 
the critical electronic subsystems segment includes sales of critical electronic subsystems for medical applications which are classified as medical imaging products but which are manufactured within this segment  of approximately million  million and million  respectively  for fiscal years ended august   august  and july  aggregate sales of medical products were approximately million  million and million  respectively  for fiscal years ended august   august  and july  results of operations the following table sets forth  for the years indicated  the percentage of net sales represented by items as shown in the company s consolidated statements of income 
fiscal years ended august  august  july  net sales costs and expenses cost of sales research and development selling  general and administrative interest income expense net 
income before provision for income taxes provision for income taxes net income fiscal years  and net sales for the critical electronic subsystems segment for fiscal were approximately million compared to approximately million for fiscal  an increase of 
net sales for the critical electronic subsystems segment for fiscal were approximately million compared to approximately million for fiscal  an increase of 
the increases were due to internal growth as the result of increased demand for the company s products 
net sales for the medical systems segment were approximately million for fiscal compared to approximately million for fiscal  an increase of 
this increase was due to the inclusion of gendex del for the whole year  which contributed an increase of approximately million  which was partially offset by reduced sales of portable x ray systems of approximately million 
fiscal included large initial orders for portable x ray systems into the state of michigan and to the united states marine corps 
net sales for the medical systems manufacturing segment were approximately million for fiscal as compared to approximately million in fiscal  an increase of 
the increase was due to internal growth of dynarad of approximately million and the acquisition of the gendex del subsidiary  which occurred in march cost of sales for the critical electronic subsystems segment decreased to of net sales in fiscal from of net sales in fiscal cost of sales for the critical electronic subsystems segment decreased to of net sales in fiscal from of net sales in fiscal the decrease in cost of sales as a percentage of net sales in fiscal years and were primarily due to improved operating efficiencies and a favorable product mix 
cost of sales in fiscal for the medical systems segment decreased to of net sales from of net sales in fiscal cost of sales in fiscal for the medical systems segment decreased to of net sales from of net sales in fiscal the fiscal and improvements in margins from fiscal are due to the reduced manufacturing cost from efficiencies implemented in this segment in both the gendex del and dynarad subsidiaries and to the transfer of manufacturing of certain of the dynarad systems to gendex del 
research and development costs  for the critical electronic subsystems segment  increased to approximately million in fiscal from approximately million in fiscal research and development costs  for the critical electronic subsystems segment  increased to approximately million in fiscal from approximately million in fiscal these increases were due to new products being developed in this segment 
research and development costs in the medical systems segment increased to approximately million in fiscal from approximately  in fiscal research and development costs in the medical systems segment increased to approximately  in fiscal from approximately  in fiscal these increases were attributable to increased research and development at dynarad and to the inclusion of the research and development of the gendex del subsidiary for all of fiscal and part of fiscal selling  general and administrative expenses  as a percentage of sales  in the critical electronic subsystems segment  were approximately million or of net sales in fiscal as compared to approximately million or of net sales in fiscal the increase in selling  general and administrative expenses was primarily due to the addition of several new regional marketing managers  higher levels of advertising  trade show attendance  marketing expenses and increased amortization of deferred charges in fiscal as compared to fiscal selling  general and administrative expenses  as a percentage of sales  in the critical electronic subsystems segment  were approximately million or of net sales in fiscal as compared to approximately million or of net sales in fiscal the decrease was due to lower levels of advertising and trade show attendance 
selling  general and administrative expenses  for the medical systems segment  were approximately million or of net sales in fiscal as compared to approximately million or of net sales in fiscal the increase was due to higher levels of advertising  trade show attendance and an increase in amortization of certain intangible assets 
selling  general and administrative expenses  for the medical systems segment  were approximately million or of net sales in fiscal as compared to approximately million or of net sales in fiscal the reduction of selling  general and administrative expenses as a percentage of sales was due primarily to the increased sales volume with the acquisition of gendex del in march interest income for fiscal was approximately  net of interest expense of approximately  such interest expense included the amortization of the company s interest rate protection agreements of approximately  and approximately  of bank commitment fees on unused balances 
the company s reduction in interest from fiscal is due to the repayment of substantially all of its bank borrowings as the result of the equity offering completed in july interest expense  net of interest income  for fiscal and was approximately million and million  respectively 
interest expense decreased in fiscal as the result of the completion of an equity offering in july and subsequent debt repayments 
income tax expense decreased to of pre tax income in fiscal from of pre tax income in fiscal  primarily due to the reinstatement of the research and development tax credits for all of fiscal income tax expense increased to of pre tax income in fiscal from of pre tax income in fiscal  primarily due to the effect of lower research and development tax credits available in fiscal due to the timing of the reinstatement of this tax credit 
fiscal includes only one month of this tax credit as compared to fiscal which has a full year of this tax credit 
net income for fiscal was approximately million  an increase of from approximately million in fiscal net income for fiscal was approximately million  an increase of from approximately million in fiscal primary and fully diluted earnings per share for fiscal were  an increase of 
per share which represents a increase from primary and fully diluted earnings per share of 
in fiscal primary and fully diluted earnings per share for fiscal were  an increase of 
per share which represents a increase from primary earnings per share of 
in fiscal the number of outstanding shares and common share equivalents increased from approximately million shares in fiscal to approximately million shares in fiscal or  primarily due to the results of the public offering of  shares completed in july the increases in net income and earnings per share for fiscal as compared to fiscal were due to internal growth  improved gross margins due to operating efficiencies  the inclusion of the operations of the gendex del subsidiary for a full year in fiscal and the repayment of bank borrowings in the fourth quarter of fiscal the increases in net income and earnings per share for fiscal as compared to fiscal were due to internal growth and the addition of the gendex del subsidiary in march analysis of financial condition liquidity and capital resources 
the company has funded its operations and acquisitions through a combination of cash flow from operations  bank borrowing and the issuance of common stock 
cash flows from operations were approximately million  million and million for the fiscal years ended august   august  and july   respectively 
at august  the company had a current ratio of approximately to and the availability of approximately million of bank borrowings under its lines of credit 
equity financing 
in july  the company completed a public offering of  shares of its common stock  including  shares of the over allotment option 
the net proceeds of this offering were approximately million after deducting underwriters fees and expenses 
working capital 
at august  and august   the company s working capital was approximately million and million  respectively 
at such dates the company had approximately million and million  respectively  in cash and cash equivalents 
trade receivables at august  increased approximately million as compared to august  primarily due to higher shipping levels during the company s fourth quarter in fiscal compared to fiscal trade receivables at august  increased approximately million as compared to july  primarily as the result of the inclusion of the gendex del receivables of approximately million in fiscal year cost and estimated earnings in excess of billings on uncompleted contracts of approximately million at august  relate to long term contracts which are accounted for under the percentage of completion method of accounting 
inventory at august  increased by approximately  as compared to august   primarily at gendex del 
inventory at august  increased approximately million as compared to july  approximately million of this increase was due to the inclusion of the gendex del inventory and the balance due to higher business levels at the company s other operating units 
prepaid expenses and other current assets increased approximately  at august  as compared to august  this increase was primarily attributable to prepaid insurance and other prepaid items 
prepaid expenses and other current assets increased approximately  at august  as compared to july  this increase in prepaid expenses and other current assets was primarily attributable to advanced payments for inventory of del medical systems and rfi corporation under their exclusive distribution agreement for diagnostic medical image enhancers and filtered connectors and the prepaid expenses of gendex del 
accounts payable increased by approximately  at august  as compared to august  this increase was attributable to higher levels of inventory required for fiscal shipments 
accounts payable increased by approximately million at august  as compared to july   which was primarily attributable to the inclusion of accounts of gendex del  partly offset by lower levels of payables at the other operating units 
accrued liabilities increased by approximately  at august  as compared to august  the increase was due to higher amounts accrued for vacations and other personnel costs 
accrued liabilities increased by approximately million at august  as compared to july   which was primarily attributable to the inclusion of gendex del and taxes payable 
deferred compensation liability increased by approximately  at august  as compared to august   of this increase relates to the fiscal funding of deferred compensation and approximately  relates to recognized and unrealized gains  on the underlying investments 
deferred compensation liability increased by approximately  at august  as compared to july   of this increase relates to the fiscal funding of deferred compensation and approximately  relates to recognized and unrealized gains  on the underlying investments 
gains and losses  either recognized or unrealized  inure to the benefit or detriment of the president  under a contractual arrangement between the president and the company 
credit facility and borrowing 
on march   in connection with the acquisition of gendex  the company and its lending bank entered into an amended and restated credit agreement wherein the bank increased the company s line of credit to million  consisting of a five year million term loan and a four year revolving line of credit of million 
in connection with the gendex acquisition  on march  the company delivered a seven year million subordinated note to dentsply international inc the company on june   after partially completing the sale of  shares of common stock was able to repay the dentsply loan and all but  of its bank borrowing 
on august   the company and its lending bank amended their credit agreement to allow for a five year million acquisition credit line to replace the five year term loan 
borrowings under the company s amended credit agreement are now on an unsecured basis 
on august   the company and its lending bank further amended their credit agreement to increase the provision for letters of credit from  to  to eliminate the requirement to provide interest rate protection contracts unless the company s borrowings on term loans exceed  to eliminate the requirement to prepare monthly borrowing base certificates until the company s borrowings and letters of credit outstanding exceed  to increase the amount that the company can invest in other entities without bank prior approval from  to  and to provide for a fixed rate interest option  at the company s request 
at august   the company had approximately million available under its revolving line of credit  after deducting letters of credit outstanding of approximately  and approximately million available under its acquisition credit line 
capital expenditures 
the company continues to invest in capital equipment  principally for its manufacturing operations  in order to improve its manufacturing capabilities and capacity 
the company has expended approximately million  million and million  respectively  for capital equipment expenditures in fiscal years  and  respectively 
shareholders equity 
shareholders equity increased to approximately million at august  from approximately million at august   primarily due to the results of operations 
additionally  during fiscal approximately  stock options and warrants were exercised  with proceeds of approximately  and  shares of common stock were repurchased at a cost of approximately  effects of new accounting pronouncements earnings per share 
in february  the financial accounting standards board fasb issued statement of financial accounting standards sfas no 
 earnings per share 
this statement is effective for financial statements issued for periods ending after december  management has evaluated the effect on its financial reporting from the adoption of this statement and believes it will be significant 
if sfas no 
were effective for the fiscal year ended august   the effect of implementation would have resulted in basic earnings per share of 
and diluted earnings per share of 
disclosure of information about capital structure 
in february  the fasb issued sfas no 
disclosure of information about capital structure 
this statement is effective for years ending after december  management has evaluated the effect of this statement on its financial reporting and  as it contains no change in disclosure requirements for entities that were previously subject to the requirements of apb opinions  and  no further disclosures are needed 
reporting of comprehensive income 
in february  the fasb issued sfas no 
reporting of comprehensive income 
this statement is effective for years ending after december  management has evaluated the effect of this statement on its financial reporting from the adoption of this statement and has found that no further disclosures are needed 
disclosures about segments of an enterprise and related information 
in june  the fasb issued sfas no 
disclosures about segments of an enterprise and related information 
sfas no 
requires the reporting of profit and loss  specific revenue and expense items  and assets for reportable segments 
it also requires the reconciliation of total segment revenues  total segment profit and loss  total segment assets and other amounts disclosed for segments to the corresponding amounts in the general purpose financial statements 
this statement is effective for financial statements issued for periods ending after december  the company has not yet determined what additional disclosures may be required in connection with adopting sfas no 

